The US Centers for Disease Control and Prevention (CDC) today reported three new infections involving novel influenza A viruses, two of them variant H3N2 (H3N2v) and one variant H1N2 (H1N2v), with possible human-to-human transmission in one of the cases.
The Saudi Arabian Ministry of Health (MOH) reported two new cases of MERS-CoV infection yesterday and today and the death of a previously reported patient.
A 49-year-old Saudi man from Unayzah is in critical condition after presenting with symptoms of MERS-CoV (Middle East respiratory syndrome coronavirus), the MOH reported yesterday. The man had indirect contact with camels, a known risk factor for MERS.
The number of confirmed, probable, and suspected cases in Madagascar's plague outbreak has climbed to 849, 67 of them fatal, the World Health Organization (WHO) said yesterday in an update. The totals reflect increases of 165 cases and 10 deaths since the WHO's last report on Oct 12.
The findings are consistent with patterns seen during a 2013 Zika outbreak in French Polynesia.
The World Health Organization (WHO) today said it has received word of an attack at medical facilities in Syria that destroyed the only vaccines cold room in a district where several polio cases have been reported over the past several months.
The Florida Department of Health (Florida Health) today reported the state's first locally acquired Zika case of the year, putting the nation's total this year at three local cases.
In a statement, Florida Health said the locally transmitted case has been confirmed in Manatee County, which wasn't one of the areas to report cases last year.
The Texas case is in a county where illnesses were reported last year.
Comprehensive biomedical research must continue its crucial role in preparing the world for the next pandemic or other far-reaching public health emergency, whether it be caused by a novel influenza strain, Ebola, or some other transmissible pathogen, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) and colleagues wrote in a commentary in the Journal
The trial of 40 adults with 2 dose levels found the vaccine safe and immunogenic.
In one case, relying on ultrasound alone would have given the mother false assurance.
